/
you're reading...

Zoetis launches LIBRELA® and SOLENSIA® in Europe, the first products in a new class of medications for the management of osteoarthritis (OA) pain in dogs and cats in 20 years

Librela® and Solensia® effectively relieve osteoarthritis pain for a month with a positive safety profileZoetis has announced the launch of Librela (bedinvetmab) in the European...

Read full story

Archives